Effect of Omeprazole on Gastric Mucosa and Serum Levels of Amoxicillin in Patients with Non-Ulcer Dyspepsia

Journal of the Medical Association of Thailand

Volumn 83, Issue 6, 2000, Pages 611-618

  Wittayalertpanya, Supeecha ^a   Thongnopnua, Phensri ^a   Wannachai, Natnipa ^a   Mahachai, Varocha ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Amoxicillin; Gastric Mucosa; Omeprazole

Indexed keywords

AMOXICILLIN; ENZYME INHIBITOR; OMEPRAZOLE; PENICILLIN DERIVATIVE;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG INTERACTION; DYSPEPSIA; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PROBABILITY; REFERENCE VALUE; STOMACH MUCOSA;

ADULT; AMOXICILLIN; DRUG INTERACTIONS; DYSPEPSIA; ENZYME INHIBITORS; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PROBABILITY; REFERENCE VALUES;

EID: 0034201918     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pajares JM. Helicobacter pylori infection : its role in chronic gastritis, carcinoma and peptic ulcer. Hepato-Gastroenterol 1995; 42: 827-41.
2. Forbes GM, Glaser ME, Cullen DJE, Warren JR, Christiansen KJ, Marshall JR. Duodenal ulcer treated with Helicobacter pylori eradication : seven-year follow-up. Lancet 1994; 343: 258-60.
3. Gad A, Unge P. Editorial : antibacterial therapy of Helicobacter pylori -associated peptic ulcer disease : a new strategy, the Swedes go for it. J Clin Gastroenterol 1994; 19: 6-10.
4. McKinlay AW. Antibiotics in the treatment of peptic ulcer disease. J of Antimicrob & Chemother 1995; 35: 92-6.
5. Seppala K, Pikkarainen P, Sipponen P, Kivilaakso E, Gormsen MH. Cure of peptic ulcer associated with eradication of Helicobacter pylori. Gut 1995; 36: 834-4.
6. Tytgat GNJ. Review of article: treatment that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol & Therpeutics 1994; 8: 359-68.
7. Bayerdrorffer E, Mannes GA, Sommer A, et al. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J of Gastroenterol & Hepatol 1992; 4: 697-702.
8. Adamek RJ, Wegner M, Labenz J, Freitag M, Opferkuch W, Ruhl GH. Medium-term results of oral and intravenous omeprazole, amoxicillin Helicobacter pylori eradication therapy. Am J of Gastroenterol 1994; 89: 39-42.
9. Labenz J, Borsh G. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J of Gastroenterol 1994; 89: 1785-8.
10. van dur Hulst Rw, Weel JF, Verheul SB, et al. Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxicillin and the effect of early retreatment. Aliment Pharmacol & Therapeutics 1996; 10: 165-71.
11. 2 receptor antagonist-implications for treatment of Helicobacter pylori infections. Digest Dis and Science 1991; 36: 25-8.
12. United States Pharmacopeial convention, INC. The United States Pharmacopeia 23 the National Formulary 18. MA: Rand Mcnally; 1995: 100.
13. Charles B, Chulavatnatol S. Simple analysis of amoxycillin in plasma by high performance liquid chromatography. Biomed Chromatography 1993; 7: 204-7.
14. Axon AVR. The role of acid inhibition in the treatment of Helicobacter pylori infection. J of Gastroenterol 1994; 29 suppl 201: 16-23.
15. Hoover JE. Remington's Pharmaceutical Sciences. 15th ed. Mack Publishing Co, Easton, PA; 1975: 1128-33.
16. Cooreman MP, Krausgrill P, Hengels KJ. Local gastric and serum amoxicillin concentrations after different oral application forms. Antimicrob Agents Chemother 1993; 37: 1506-9.
17. McNulty CAM, Dent JC, Ford GA, Wilkinson SP. Inhibitory antimicrobial concentrations against Campylobacter pylon in gastric mucosa. J of Antimicrob Chemother 1988; 22: 729-38.
18. Cardaci G, Lambert JR, Aranda-Michel J, Underwood B. Omeprazole has no effect on the gastric mucosal bioavailability of amoxycillin. Gut 1995 : A358.
19. Goddard AF, Jessa MJ, Barrett DA, et al. Effect of omeprazole on the distribution of metronidazole, amoxicillin and clarithromycin in human gastric juice. Gastroenterology 1996; 111: 358-67.
20. Pommerien W, Braun M, Idstrom JP, Wrangstadh M, Londong W. Pharmacokinetic and pharmacodynamic interactions between omeprazole and amoxicillin in Helicobacter pylori-positive healthy subjects. Aliment Pharmacol & Therapeutic 1996; 10: 295-301.
21. Hunt RH. Hp and pH-the relevance of gastric acid to the treatment of Helicobacter pylori infection. J of Gastroenterol 1994; 29: 128-33.
22. Nagata K, Satoh H, Iwahi T, et al. Potent inhibitory action of the gastric proton pump inhibitor lanzoprazole against urease activity of Helicobacter pylori: Unique action selective for H.pylori cells. Antimicrob Agents Chemother 1993; 37: 769-74.
23. Sjostrom JE, Larsson H. Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant. J Med Microbiol 1996; 44: 425-33.
24. Cederbrant G, Kahlmeter G, Schalen C, Kamme C. Additive effect of clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori. J of Antimicrob Chemother 1994; 34: 1024-9.
25. Grayson ML, Eliopoulos GM, Ferraro MJ, Moellering RC Jr. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. Eur J Clin Microbiol Infect Dis 1989; 8: 888-9.